Group A and C meningococcal polysaccharide vaccine (Lanzhou Institute of Biological Products)

A群C群脑膜炎球菌多糖疫苗（兰州生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup A and C meningococcal polysaccharide vaccine (Lanzhou Institute of Biological Products)
Drug Alias Namemeningococcal A/C polysaccharide vaccine (Lanzhou Institute of Biological Products)梦灵康Meng Ling Kang
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitis, Meningococcal
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaMeningitis, Meningococcal
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH03
Related LinksN/A